THERAPEUTIC TARGETING OF ONCOGENES

Grant number: 1106576 | Funding period: 2016 - 2020

Completed

Abstract

Treatments that target cancer causing genes called oncogenes have resulted in new treatment paradigms for cancer. We suggest that outcomes of patients with cancer will be further substantially improved by understanding how cancers can overcome resistance to these treatments that develops in many patients. To accelerate the adoption of these and other new treatments for cancer we will also develop new frameworks for clinical trials.

Related publications (4)

Researchers